Marcus Feith

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. pmc The simultaneous expression of both ephrin B3 receptor and E-cadherin in Barrett`s adenocarcinoma is associated with favorable clinical staging
    Matthias C Schauer
    Department of Radiotherapy, Heinrich Heine University, Duesseldorf, Germany
    Eur J Med Res 17:10. 2012
  2. pmc High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma
    Sandra Rauser
    Institute of Pathology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Ingolstaedter Landstr 1, 85764 Neuherberg, Germany
    BMC Cancer 10:608. 2010
  3. pmc Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus
    Rupert Langer
    Institute of Pathology, TU Munchen, Munchen, Germany
    BMC Cancer 8:70. 2008
  4. doi request reprint Testicular metastasis from adenocarcinoma of the esophagus
    Sonja Gillen
    Department of Surgery, Technische Universitat Munchen, Klinikum rechts der Isar, Munich, Germany
    Ann Thorac Surg 87:957-9. 2009
  5. ncbi request reprint Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients
    Marcus Feith
    Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaningerstr 22, 81675 Munchen, Germany
    Surg Oncol Clin N Am 15:751-64. 2006
  6. doi request reprint Healing occurs in most patients that receive endoscopic stents for anastomotic leakage; dislocation remains a problem
    Marcus Feith
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Clin Gastroenterol Hepatol 9:202-10. 2011
  7. doi request reprint Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system
    Ralf Gertler
    Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Ann Surg 253:689-98. 2011
  8. doi request reprint High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients
    Rupert Langer
    Institute of Pathology, Technische Universitat Munchen, Munchen, Germany
    J Surg Oncol 102:503-8. 2010
  9. doi request reprint Prevalence and topography of lymph node metastases in early esophageal and gastric cancer
    Ralf Gertler
    Chirurgische Klinik und Poliklinik Klinik für Allgemein, Viszeral und Thoraxchirurgie, Klinikum Nurnberg Nord, Nurnberg, Germany Institut für Medizinische Statistik und Epidemiologie and Institut für Allgemeine Pathologie und Pathologische Anatomie, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Ann Surg 259:96-101. 2014
  10. pmc Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas
    Julia Slotta-Huspenina
    Institute of Pathology, Technische Universitat Munchen, Munich, Germany
    PLoS ONE 7:e41420. 2012

Collaborators

Detail Information

Publications55

  1. pmc The simultaneous expression of both ephrin B3 receptor and E-cadherin in Barrett`s adenocarcinoma is associated with favorable clinical staging
    Matthias C Schauer
    Department of Radiotherapy, Heinrich Heine University, Duesseldorf, Germany
    Eur J Med Res 17:10. 2012
    ..In order to study this tumor suppressor activity of Eph B3 in esophageal adenocarcinoma we analyzed the simultaneous expression of Eph B3 and E-cadherin in both the healthy esophagus and in Barrett's carcinoma...
  2. pmc High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma
    Sandra Rauser
    Institute of Pathology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Ingolstaedter Landstr 1, 85764 Neuherberg, Germany
    BMC Cancer 10:608. 2010
    ..Here we evaluated the impact of TILs on survival, recurrence, and metastasis in Barrett's cancer, particularly in stage I-IIA patients...
  3. pmc Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus
    Rupert Langer
    Institute of Pathology, TU Munchen, Munchen, Germany
    BMC Cancer 8:70. 2008
    ..In this study we investigated the glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in a series of human esophageal adenocarcinomas to determine their implications in cancer progression and prognosis...
  4. doi request reprint Testicular metastasis from adenocarcinoma of the esophagus
    Sonja Gillen
    Department of Surgery, Technische Universitat Munchen, Klinikum rechts der Isar, Munich, Germany
    Ann Thorac Surg 87:957-9. 2009
    ..In most cases, the testicular tumor was accompanied by a hydrocele. Therefore, cancerous and metastatic lesions should be considered in the management of hydrocele and testicular masses...
  5. ncbi request reprint Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients
    Marcus Feith
    Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaningerstr 22, 81675 Munchen, Germany
    Surg Oncol Clin N Am 15:751-64. 2006
    ..With better surgical management and standardized procedures, even the results in patients with more radical surgical approaches, the abdomino-thoracic esophagectomy improved...
  6. doi request reprint Healing occurs in most patients that receive endoscopic stents for anastomotic leakage; dislocation remains a problem
    Marcus Feith
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Clin Gastroenterol Hepatol 9:202-10. 2011
    ..We evaluated the effects of treatment with self-expanding metal stents in patients with esophageal anastomotic leakage after esophagectomy or gastrectomy for cancer...
  7. doi request reprint Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system
    Ralf Gertler
    Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Ann Surg 253:689-98. 2011
    ..We analyzed the long-term outcome of patients operated for esophageal cancer and evaluated the new seventh edition of the tumor-node-metastasis classification for cancers of the esophagus...
  8. doi request reprint High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients
    Rupert Langer
    Institute of Pathology, Technische Universitat Munchen, Munchen, Germany
    J Surg Oncol 102:503-8. 2010
    ....
  9. doi request reprint Prevalence and topography of lymph node metastases in early esophageal and gastric cancer
    Ralf Gertler
    Chirurgische Klinik und Poliklinik Klinik für Allgemein, Viszeral und Thoraxchirurgie, Klinikum Nurnberg Nord, Nurnberg, Germany Institut für Medizinische Statistik und Epidemiologie and Institut für Allgemeine Pathologie und Pathologische Anatomie, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Ann Surg 259:96-101. 2014
    ..To determine the prevalence and localization of lymph node metastases in patients with pT1 carcinoma of the esophagus, esophagogastric junction, and stomach...
  10. pmc Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas
    Julia Slotta-Huspenina
    Institute of Pathology, Technische Universitat Munchen, Munich, Germany
    PLoS ONE 7:e41420. 2012
    ..Our approach may be helpful for identifying candidates for specific HSP/GRP-targeted therapies...
  11. doi request reprint How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
    Ralf Gertler
    Department of Surgery, Technische Universitat Munchen, Munich, Germany
    Am J Surg Pathol 35:1512-22. 2011
    ..To evaluate whether so-called cardiac adenocarcinomas (adenocarcinomas of the esophagogastric junction type II and III, ie AEG II and III) are better staged as cancers of the esophagus or as cancers of the stomach...
  12. doi request reprint Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas
    Rupert Langer
    Institute of Pathology, Technische Universitat Munchen, Munchen, Germany
    Mod Pathol 22:1555-63. 2009
    ..Therefore, we strongly recommend the implementation of a standardized tumor regression grading system in pathological reports of esophageal adenocarcinomas treated by neoadjuvant chemotherapy...
  13. ncbi request reprint Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma
    Rupert Langer
    Institute of Pathology and Medical Statistics, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Clin Cancer Res 11:7462-9. 2005
    ..We analyzed pretherapeutic gene expression patterns of patients with locally advanced adenocarcinomas of the esophagus with regard to response to neoadjuvant chemotherapy...
  14. doi request reprint Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis
    Michael Kranzfelder
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Straße 22, 81675, Munich, Germany
    Surg Endosc 27:3530-8. 2013
    ..Esophagectomy is a challenging operation with considerable potential for postoperative complications, including chylothorax...
  15. doi request reprint Microarray-based response prediction in esophageal adenocarcinoma
    Matthias Schauer
    Department of Surgery, Technische Universitaet Muenchen, Munich, Germany
    Clin Cancer Res 16:330-7. 2010
    ..However, only a subgroup of patients responds. Therefore, in the present study, we evaluated whether the response to neoadjuvant chemotherapy can be predicted by a pretreatment tumor biopsy analysis...
  16. ncbi request reprint Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification
    J Rudiger Siewert
    Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    J Surg Oncol 90:139-46; discussion 146. 2005
    ..The subclassification of AEG tumors thus provides a useful tool for the selection of the surgical procedure and allows a better comparison of treatment results...
  17. ncbi request reprint Sentinel node detection in Barrett's and cardia cancer
    Maria Burian
    Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    Ann Surg Oncol 11:255S-8S. 2004
    ..The concept of sentinel lymph node mapping and detection thus may open the door to individualized therapy for patients with high-grade dysplasia in a Barrett's esophagus or with early Barrett's and cardia cancer...
  18. pmc Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection
    Hubert J Stein
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    Ann Surg 242:566-73; discussion 573-5. 2005
    ..The objective of this study was to assess the prevalence and pattern of lymphatic spread in patients with early squamous cell and adenocarcinoma and identify prognostic factors for long-term survival after resection and lymphadenectomy...
  19. pmc Discovery of new molecular subtypes in oesophageal adenocarcinoma
    Daniela Berg
    Institute of Pathology, Technische Universitat Munchen, Munich, Germany
    PLoS ONE 6:e23985. 2011
    ..After confirmation in other independent studies, our results could be the foundation for the development of a Her2-targeted treatment option for this new patient subgroup of oesophageal adenocarcinoma...
  20. doi request reprint Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation
    Rupert Langer
    Institute of Pathology, Technische Universitat Munchen, Munich, Germany
    Mod Pathol 24:908-16. 2011
    ..Assessment of ErbB2 amplification can be equivalently performed by conventional fluorescence in situ hybridisation or other light-microscopy-based methods, such as the novel bright field double in situ hybridisation technique...
  21. ncbi request reprint Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer
    J Rudiger Siewert
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    J Am Coll Surg 205:S49-53. 2007
  22. doi request reprint Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review
    Ralf Gertler
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Am J Gastroenterol 104:2838-51. 2009
    ..The aim of this report was to assess the value of pouch formation as a gastric substitute after total gastrectomy compared with reconstruction techniques without a pouch...
  23. ncbi request reprint Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction
    Burkhard H A von Rahden
    Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    J Clin Oncol 23:874-9. 2005
    ..To evaluate the value of lymphatic vessel invasion (LVI) as a predictor of survival in patients with primary resected adenocarcinomas of the esophagogastric junction (AEG)...
  24. doi request reprint Results of a multimodal therapy in patients with stage IV Barrett's adenocarcinoma
    Matthias Schauer
    Department of Surgery, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaninger Strasse 22, 81675, Munich, Germany
    World J Surg 32:2655-60. 2008
    ..The benefit of a multimodal therapy concept in patients with stage IV disease remains unclear...
  25. doi request reprint Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding protein
    Elke Prade
    Department of Chemistry, Klinikum rechts der Isar, Technische Universitat Munchen, D 81675 Munich, Germany
    Mol Endocrinol 26:819-32. 2012
    ..These data indicate that bile acid-mediated down-regulation of Cav1 marks early changes in the squamous epithelium, which may contribute to onset of Barrett esophagus metaplasia and progression to BAC...
  26. doi request reprint Cholecystectomy in the very elderly--is 90 the new 70?
    Attila Dubecz
    Department of Surgery, Klinikum Nürnberg, Nuremberg, Germany
    J Gastrointest Surg 16:282-5. 2012
    ..Nonagenarians are the fastest growing sector of population across Western Europe. Although prevalence of gallstone disease is high, elective cholecystectomy is still controversial in this age group...
  27. doi request reprint Clinical significance of the costimulatory molecule B7-H1 in Barrett carcinoma
    Martin Loos
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Ann Thorac Surg 91:1025-31. 2011
    ..To date, no data are available on the role of B7-H1 in Barrett carcinoma. Therefore, we investigated the expression pattern and clinical significance of B7-H1 in a large cohort of patients with Barrett carcinoma...
  28. doi request reprint Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases
    Rupert Langer
    Institute of Pathology, Technische Universitat Munchen, Munchen, Germany
    Mod Pathol 24:495-501. 2011
    ..We conclude that molecular analysis can identify targets for a specific therapy such as tyrosin kinase inhibitors as additional treatment option in these highly malignant tumors...
  29. doi request reprint Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study
    Rupert Langer
    Institute of Pathology, Technische Universitat Munchen, Munich, Germany
    J Clin Pathol 63:994-8. 2010
    ..Deregulation of HDACs has been detected in various human malignancies and may also influence response to chemotherapy...
  30. ncbi request reprint Carcinoma of the cardia: classification as esophageal or gastric cancer?
    Burkhard H A von Rahden
    Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar der TU Munchen, Ismaningerstrasse 22, 81675 Munich, Germany
    Int J Colorectal Dis 20:89-93. 2005
    ..Controversy exists concerning their appropriate classification and whether these tumors comprise--in respect to tumor biology, pathophysiology as well as clinical features--an entirely separate entity...
  31. ncbi request reprint Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma
    Christian Möbius
    Department of Surgery, Klinikum rechts der Isar der TU Munchen, Ismaningerstrasse 22, München D 81677, Germany
    World J Surg 28:675-9. 2004
    ..However, VEGF does not appear to be the vascular growth factor stimulating neovascularization in Barrett's carcinoma patients...
  32. doi request reprint Simultaneous/Incidental cholecystectomy during gastric/esophageal resection: systematic analysis of risks and benefits
    Sonja Gillen
    Department of Surgery, Technische Universitat Munchen, Ismaningerstrasse 22, 81675, Munich, Germany
    World J Surg 34:1008-14. 2010
    ..The clinical relevance of gallstones and the role of simultaneous/incidental cholecystectomy in this setting are controversially discussed...
  33. ncbi request reprint Approach to early Barrett's cancer
    Hubert J Stein
    Chirurgische Klinik und Poliklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaningerstrasse 22, D 81675, Munchen, Germany
    World J Surg 27:1040-6. 2003
    ..In contrast, endoscopic interventions are plagued by a high tumor recurrence rate, probably from persistence of Barrett's mucosa and gastroesophageal reflux...
  34. doi request reprint Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center
    Katja Ott
    Department of Surgery, University of Heidelberg, Heidelberg, Germany
    Ann Surg Oncol 16:1017-25. 2009
    ..Thus, we evaluated the surgical risk and outcome after an abdominothoracic esophagectomy (Ivor-Lewis) with intrathoracic anastomosis as standard procedure...
  35. ncbi request reprint Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett's cancer)
    J Rudiger Siewert
    Chirurgische Klinik und Poliklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaningerstrasse 22, D 81675 Munchen, Germany
    World J Surg 27:1058-61. 2003
    ..The overall 5-year survival rate of more than 40%, which is superior to most published data, supports this therapeutic strategy...
  36. ncbi request reprint Pattern of lymphatic spread of Barrett's cancer
    Marcus Feith
    Chirurgische Klinik und Poliklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaningerstrasse 22, D 81675 Munchen, Germany
    World J Surg 27:1052-7. 2003
    ..These observations set the stage for individualized and tailored lymphadenectomy strategies. The sentinel lymphadenectomy concept may be applicable to patients with early Barrett's cancer...
  37. doi request reprint Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches
    Eva Karamitopoulou
    Institute of Pathology, University of Bern, Bern, Switzerland Department of Surgery, University of Heidelberg, Heidelberg Department of Surgery, Klinikum Rechts der Isar Institute of Pathology, Technische Universitat Munchen, Munich University Cancer Center Leipzig, Leipzig, Germany
    Am J Surg Pathol 38:1551-6. 2014
    ..A simple 3-tiered system with the estimation of residual tumor in % (complete regression/1% to 50% residual tumor/>50% residual tumor) maintains the highest reproducibility and prognostic value. ..
  38. doi request reprint Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis
    Attila Dubecz
    Department of Surgery, Klinikum Nürnberg, Nuremberg, Germany
    J Thorac Oncol 7:443-7. 2012
    ..To assess long-term temporal trends in population-based survival and cure rates in patients with esophageal cancer and compare them over the last 3 decades in the United States...
  39. doi request reprint Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma
    Ralf Gertler
    Department of Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
    Cancer 112:2173-80. 2008
    ..The authors evaluated telomere length and telomerase subunits, hTR and hTERT, as prognostic markers in patients with Barrett carcinoma...
  40. ncbi request reprint Long-term Outcome of 2920 Patients With Cancers of the Esophagus and Esophagogastric Junction: Evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee Staging System
    Ralf Gertler
    Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany Klinik für Allgemein, Viszeral und Thoraxchirurgie, Klinikum Nurnberg Nord, Nurnberg, Germany Institut für Pathologie und Pathologische Anatomie Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany Universitätsklinikum Heidelberg, Heidelberg, Germany
    Ann Surg 253:689-98. 2011
    ..We analyzed the long-term outcome of patients operated for esophageal cancer and evaluated the new seventh edition of the tumor-node-metastasis classification for cancers of the esophagus...
  41. pmc Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus
    Julia Slotta-Huspenina
    Institute of Pathology, Technische Universitat Munchen, München 81765, Germany
    Cancers (Basel) 6:1382-93. 2014
    ..Anti-HSP90 drugs, which recently have been introduced in cancer treatment, may also be an option for these tumors by targeting HSP90 alone or in combination with Her2. ..
  42. doi request reprint The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological study
    Florian Liebl
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany Institute of Medical Statistics and Epidemiology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany Institute of Pathology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany Institute of Pathology, University of Heidelberg, Heidelberg, Germany Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Department of Hepatic, Biliary and Pancreatic Surgery, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China aThese authors have contributed equally to this manuscript
    Ann Surg 260:900-7; discussion 907-8. 2014
    ....
  43. doi request reprint Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier
    Benjamin Balluff
    Department of Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
    J Proteome Res 9:6317-22. 2010
    ....
  44. doi request reprint What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
    Ralf Gertler
    Chirurgische Klinik und Poliklinik, Technische Universitat Munchen, Munich, Germany
    J Surg Oncol 114:428-33. 2016
    ..The management of R1-resected adenocarcinoma of the esophagogastric junction (AEG) is unclear. We aimed to identify risk factors and prevalence of R1 resections, their recurrence and prognosis, and efficacy of postoperative therapy...
  45. doi request reprint Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT
    Stefan Münch
    Department of Radiation Oncology, Klinikum rechts der Isar, TU Munchen, Ismaninger Str 22, 81675, Munchen, Germany
    Strahlenther Onkol 192:722-9. 2016
    ..This study compares dosimetric parameters and toxicity in esophageal cancer (EC) patients treated with VMAT and 3D conformal radiotherapy (3D-CRT)...
  46. pmc Perivascular epitheloid cell tumor (PEComa) mimicking retroperitoneal liposarcoma
    Moritz Wildgruber
    Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar, TU Munchen, Ismaningerstrasse 22, Munchen D 81675, Germany
    World J Surg Oncol 12:3. 2014
    ..We describe the case of retroperitoneal PEComa with a liposarcoma-like appearance on cross-sectional imaging, but distinctive immunohistochemistry revealing the correct diagnosis. ..
  47. ncbi request reprint Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy
    Claus Dieter Heidecke
    Department of Surgery, Technische Universitat Munchen, Germany
    Surgery 132:495-501. 2002
    ..The effects of combined radiochemotherapy (RCTx) on T cell functions in patients with squamous cell carcinoma of the esophagus were investigated...
  48. doi request reprint Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer
    Axel Walch
    Helmholtz Zentrum Munchen, Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH, Institut fur Pathologie, Neuherberg, Germany
    Mod Pathol 21:544-52. 2008
    ..These results indicate that the investigated regulators of E-cadherin-mediated cell adhesion play a role in gastric carcinogenesis...
  49. ncbi request reprint VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus
    Christian Möbius
    Second Department of Surgery, University of Leipzig, Germany
    World J Surg 31:1768-72; discussion 1773-4. 2007
    ..To evaluate the rule of VEGF-C expression in esophageal cancer, we investigated 113 specimens, 59 squamous cell and 54 adenocarcinomas of the esophagus...
  50. ncbi request reprint Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis
    Burkhard H A von Rahden
    Department of Surgery, Paracelsus Medical University PMU Salzburg, Salzburg, Austria
    Mol Carcinog 45:786-94. 2006
    ..The TGF-beta pathway may be a potential target for molecular therapies of advanced tumors of this entity...
  51. ncbi request reprint Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus
    Johannes Zacherl
    Universitatsklinik fur Chirurgie, Klinische Abteilung für Allgemeinchirurgie, Allgemeines Krankenhaus der Stadt Wien, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    World J Surg 27:1067-74. 2003
    ..Neoadjuvant treatment of adenocarcinoma of the esophagus, as a consequence, is currently not the standard treatment and should be performed only within controlled clinical trials...
  52. ncbi request reprint Esophageal (Barrett's) adenocarcinoma is not associated with Epstein-Barr virus infection: an analysis of 162 cases
    Mario Sarbia
    Int J Cancer 117:698-700. 2005
  53. ncbi request reprint Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus
    Hubert J Stein
    Department of Surgery, Paracelsus Private Medical University, Salzburg, Austria
    Semin Thorac Cardiovasc Surg 19:72-8. 2007
    ..Attention to technical details of limited resection and jejunal interposition is, however, required to avoid complications, poor functional results, and the need for reintervention...
  54. ncbi request reprint Scintigraphic evaluation of jejunal interposition after distal esophageal resection for early Barrett's carcinoma
    Albrecht W Stier
    Chirurgische Klinik der Ernst Moritz Arndt Universität, Friedrich Loeffler Strasse 23b, D 17487 Greifswald, Germany
    World J Surg 27:1047-51. 2003
    ..These data demonstrate good transport function and reflux prevention of short jejunal segments interposed between the esophagus and the stomach...
  55. ncbi request reprint Significance of HER2 low-level copy gain in Barrett's cancer: implications for fluorescence in situ hybridization testing in tissues
    Sandra Rauser
    Institute of Pathology, GSF National Research Center for Environment and Health, Neuherberg, Germany
    Clin Cancer Res 13:5115-23. 2007
    ..We compared three HER2 laboratory methods, standard fluorescence in situ hybridization (FISH), image-based three-dimensional FISH in thick (16 microm) sections, and immunohistochemistry, to predict patient outcome...